CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
26 hedge funds and large institutions have $28.6K invested in CERo Therapeutics Warrants in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.
2% more capital invested
Capital invested by funds: $28K → $28.6K (+$626)
13% less funds holding
Funds holding: 30 → 26 (-4)
16.38% less ownership
Funds ownership: 18.51% → 2.13% (-16%)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$1.65K |
| 2 |
Walleye Capital
New York
|
-$799 |
| 3 |
Walleye Trading
New York
|
-$193 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$3 |
| 5 |
RCM
Robinson Capital Management
Grosse Pointe Farms,
Michigan
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $1 | – | – | – |
|
|
CAC
27
Cowen and Company
New York
| – | -$3.76K | -737,168 | Closed |
|
|
28
Walleye Capital
New York
| – | -$799 | -156,576 | Closed |
|
|
RCM
29
Robinson Capital Management
Grosse Pointe Farms,
Michigan
| – | -$3 | -355 | Closed |
|
|
PA
30
Pineridge Advisors
St. Charles,
Missouri
| – | -$1 | -150 | Closed |
|
CEROW Hedge Fund Activity: Q4 2024 in Review
26 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q4 2024, worth a combined $28.6K — up 2.2% from $28K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CEROW and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Periscope Capital, cutting an estimated $1.65K.
- 26 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q4 2024, down from 30 in Q3 2024.
- Funds reported $28.6K of CERo Therapeutics Warrants stock for Q4 2024, up 2.2% quarter-over-quarter.
- 0 funds opened new CERo Therapeutics Warrants positions in Q4 2024 and 4 closed out, a net change of -4 holders.
- The largest CERo Therapeutics Warrants seller in Q4 2024 was Periscope Capital, an estimated $1.65K sold.
Based on aggregated 13F filings for Q4 2024.